References
- Cortez KJ, Roilides J, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008;21:157–197.
- Kaltseis J, Rainer J, De Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environment and their distribution in clinical samples. Med Mycol 2009;47:398–405.
- Harun A, Perdomo H, Gilgado F, et al. Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol 2009;47:406–414.
- Rodriguez-Tudela JL, Berenguer J, Guarrot J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009;47:359–370.
- Grenouillet F, Botterel F, Crouzet J, et al. Scedosporium prolificans: an emerging pathogen in France? Med Mycol 2009;47:343–350.
- Maertens J, Lagrou K, Deweerdt H, et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among hematology patients. Case report and review. Ann Hematol 2000;9:340–344.
- De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–1821.
- Senn L, Robinson JO, Schmidt S, et al. 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878–875.
- [?twbch=';']Mousset S, Bug G, Heinz WJ, Tintelnot K, Rickerts V. Breakthrough zygomycosis on posaconazole prophylaxis after allogenic stem cell transplantation. Transpl Infect Dis 2009;12:261–264.
- 10. [ri]Salmon A, Debourgogne A, Vasbien M, et al. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. Clin Microbiol Infect 2010;16:508–512.
- 11. [ri]Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol 2009;47:122–132.
- 12. [ri]Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother 2008;52:1136–1139.
- 13. [ri]Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003;47:106–117.
- 14. [ri]Kesson AM, Bellemore MC, O'Mara TJ, Ellis DH, Sorrell TC. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (Miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis 2009;48:1257–1261.
- 15. [ri]Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003;22:111–113.
- 16. [ri]Ortoneda M, Capilla R, Pastor FJ, Serena C, Guarro J. Interaction of granulocyte colony-stimulating factor and high dose of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis 2004;50:247–251.
- 17. [ri]Stimitsopoulou M, Gil-Lamaignere C, Avramidis N, et al. Antifungal activity of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans. Antimicrob Agents Chemother 2004;48:3801–3805.